Re-appointment of Dr. Mukund Gurjar as a Whole-time Director of the Company and Mr. Satish Mehta as Managing Director of the Company
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Emcure Pharmaceuticals approved the re-appointment of Dr. Mukund Gurjar as a Whole-time Director for one year from August 28, 2026, and Mr. Satish Mehta as Managing Director for five years from April 1, 2027. Both re-appointments are subject to shareholder approval. Dr. Gurjar has been associated with the company since 2001 and serves as Chief Scientific Officer, bringing technical and industrial expertise. Mr. Satish Mehta founded the company in 1981 and has been Managing Director and CEO, overseeing the company's global expansion to over 70 countries. Both directors confirmed they are not debarred from holding office and are not related to other directors or KMPs.
The re-appointment provides leadership continuity and stability for the company. Both key executives remain in their positions, which should be viewed positively by shareholders as it ensures continuity of strategy and operations. The long tenure of both directors (over two decades and four decades respectively) indicates established, experienced management.